Patient-specific ctDNA variants were also identified within alternative cancer drivers, including NRAS, HRAS, TP63, MTOR, ERBB2, EGFR, PBRM1, KMT2D and RNF43 (Fig. 4b-f). This evidence concerns the gene HRAS and cancer.